论文部分内容阅读
目的 :探讨柔脉胶囊调整血脂及抗氧化的作用。方法 :选择血脂异常患者 1 1 9例 ,治疗组 (柔脉胶囊组 ) 78例 ,对照组 (地奥心血康 ) 4 1例 ,全部连续服药 1 2周 ,观察血脂及过氧化脂质 (LPO)的变化。结果 :治疗组总胆固醇 (TC)、低密度脂蛋白胆固醇 (LDL C)和TC/高密度脂蛋白胆固醇 (HDL C)在用药后第 8、1 2周比用药前显著降低。甘油三脂 (TG)、HDL C在用药后 4、8、1 2周较用药前亦有显著下降 ,柔脉胶囊对TC、TG、HDL -C和TC/HDL C的总有效率分别为 72 .34 %、92 .5 2 %、80 .6 4%和 74.43% ,与对照组比较有显著性差异 (P <0 .0 1 )。用药前、后血清LPO比较有显著下降 (P <0 .0 1 )。结论 :柔脉胶囊有良好的调整血脂异常和抗氧化作用。
Objective: To investigate the effect of Roumai Capsule in regulating blood lipid and anti-oxidation. Methods: A total of 119 patients with dyslipidemia, 78 patients in the treatment group (Veno-Vein Capsule Group) and 41 patients in the control group (Dioxin XHX) were enrolled in this study. All the patients were continuously treated for 12 weeks. The changes of blood lipid and lipid peroxide (LPO) . Results: The levels of total cholesterol (TC), low density lipoprotein cholesterol (LDL C) and high density lipoprotein cholesterol (HDL C) in the treatment group were significantly decreased at 8 and 12 weeks after treatment. The total triglyceride (TG) and HDL C decreased significantly at 4, 8 and 12 weeks after treatment compared with those before treatment, and the total effective rates of TM, TG, HDL-C and TC / HDL C were 72 .34%, 92.52%, 80.64% and74.43%, respectively, which were significantly different from the control group (P <0.01). Serum LPO decreased significantly (P <0.01) before and after treatment. Conclusion: The Capsule has good regulation of dyslipidemia and anti-oxidation.